BRNS: Barinthus Biotherapeutics plc Company Aggregate Debts
Patents for cancer and hepatitis B treatment methods create significant barriers to entry for competitors under strict FDA oversight. The volume of credit obligations demonstrates liability dynamics, where 0.01 reflects the latest metric value. Barinthus Biotherapeutics (BRNS) is implementing energy-saving measures to comply with ESG standards, leveraging stable demand within a defensive product cycle that remains independent of global macroeconomic fluctuations.
%3A%20Company%20Debts&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_BRNS_-_Barinthus-Biotherapeutics_-_Company-Debts "Aggregate Debt Obligations: Barinthus Bio (BRNS) for 02/21/2024 - 09/19/2026 | 👁️GURU.Markets👁️")
Barinthus Biotherapeutics plc (BRNS) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- market capitalization information:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Barinthus Biotherapeutics|BRNS - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Barinthus Biotherapeutics PLC|BRNS - Company Aggregate Debts|Debts to Net Assets Barinthus Bio|BRNS - Company Long-Term Debt|Company Current Liabilities Barinthus Biotherapeutics|Quick Liquidity Indicator barinthusbio.com
- earnings and valuation multiples information:
General company analysis:BRNS, Barinthus Biotherapeutics Corp
This metric aggregates all creditor obligations, reflecting the issuer's actual debt load and financial stability. By analyzing the volume of raised capital, investors can track borrowing trends in real time, which is critical for Barinthus Biotherapeutics (BRNS) when financing costly R&D projects to develop immunotherapy drugs based on viral vectors.
Competitors of Barinthus Biotherapeutics
ARGX (argenx BVBA) - Aggregate Debt Obligations|Company Aggregate Debts BNTX (BioNTech SE)|Company Aggregate Debts Abivax Corp ABVX|ADMA - Company Debts|Aggregate Debt Obligations PTGX (Protagonist Therapeutics, Inc.)|Immunovant Corp (IMVT) - Company Debts|Company Total Debt Kiniksa Corp|GRFS (Grifols, S.A.) - Company Aggregate Debts|Company Aggregate Debts adaptivebiotech.com|Company Total Debt CLDX (Celldex Therapeutics, Inc.)|AUPH (Aurinia Pharmaceuticals Inc) - Aggregate Debt Obligations|Company Aggregate Debts BCRX (BioCryst Pharmaceuticals Inc)|Company Total Debt Obligations Vera Corp (VERA)|DNTH - Company Debts|pharvaris.com (PHVS) - Company Total Debt|AbCellera Corp (ABCL) - Company Debts|Company Total Debt Tourmaline Bio Inc|Company Total Debt PGEN|Company Aggregate Debts Pharming Corp|Company Debts Nektar Therapeutics (NKTR)|upstreambio.com - Company Aggregate Debt|Company Aggregate Debts ZBIO (Zenas Biopharma)|Immunome Inc (IMNM) - Company Cumulative Debt|Gossamer Corp - Company Aggregate Debts|KALV: Company Debts|SEPN: Company Aggregate Debts|pieris.com (PVLA) - Company Aggregate Debts|Company Debts Savara|RIGL: Aggregate Debt Obligations|Company Aggregate Debts ANAB|Company Total Debt Obligations Astria Corp|Company Debts enGene Holdings Inc. ENGN|RAPT: Company Aggregate Debt|JBIO: Company Total Debt|Aclaris Therapeutics Inc. - Company Cumulative Indebtedness|KYTX: Company Aggregate Debts|Tiziana Life Sciences, Ltd. - Aggregate Debt Obligations|Company Total Debt CABA|Company Aggregate Debts ventyxbio.com|Company Debts Theratechnologies (THTX)|Company Total Debt Obligations Avalo Therapeutics, Inc.|Eledon - Company Total Debt|Aggregate Debt Obligations AGEN|Climb Bio Inc - Company Aggregate Debts|ZURA: Company Debts|ATYR: Company Aggregate Debts|ADAG - Company Total Debt Obligations|Company Debts ImageneBio|Company Cumulative Debt Shattuck Therapeutics STTK|Company Total Debt EQ (Equillium, Inc.)|Company Cumulative Indebtedness CNTB|Company Aggregate Debts IMUX (Immunic)|Aggregate Debt Obligations ATRA|InflaRx GmbH - Company Aggregate Debts|Company Cumulative Debt X4 Pharmaceuticals, Inc|adicetbio.com (ACET) - Company Debts|Celularity - Aggregate Debt Obligations|INMB (INmune Bio) - Company Aggregate Debts|Company Aggregate Debts Kezar Life Sciences Inc.|Company Debts SAB Biotherapeutics, Inc (SABS)|AKTX: Company Aggregate Indebtedness|Company Aggregate Debts ENLV (Enlivex Therapeutics Ltd.)|Q32 Bio Inc (QTTB) - Company Cumulative Debt|GOVX: Company Total Debt|EDSA - Company Aggregate Debts|IBIO (iBio Corp) - Company Total Debt|CARM: Company Cumulative Indebtedness|XTLB (XTL Biopharmaceuticals) - Company Aggregate Debts|Bolt Bio (BOLT) - Company Total Debt Obligations|Company Aggregate Debts HCWB|Company Total Debt aptevotherapeutics.com APVO|Company Debts AIM ImmunoTech Inc. AIM|Company Total Debt Obligations Aditxt Inc. (ADTX)|GRI Bio, Inc. - Company Aggregate Debts|XRTX: Company Debts|Vyome Holdings (HIND) - Company Debts|Revelation Biosciences Inc - Aggregate Debt Obligations|Company Debts Indaptus|Company Aggregate Debt SCNI (BiondVax Pharmaceuticals)|Company Debts CalciMedica, Inc. (CALI)|Company Total Debt Obligations affimed.com|Company Debts Allakos ALLK|HOOK (HOOKIPA Pharma, Inc.) - Company Aggregate Indebtedness|IGM Bio - Company Aggregate Debts|Aggregate Debt Obligations ITOS (iTeos Pharma)|OCEA: Company Aggregate Debts|tcbiopharm.com (TCBP) - Company Aggregate Debts|Company Debts Third Harmonic Bio, Inc.